[1]
G. . Palareti, “Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results: The Apidulcis study”, Bleed Thromb Vascul Biol, vol. 1, no. 1, Mar. 2022.